ADC Toxicity Summit

ADC Toxicity Summit

 July 25 to July 27, 2023 

Hyatt Regency Boston, 1 Avenue de Lafayette, Boston, Massachusetts, 02111, United States

There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing a narrow therapeutic index. Understanding the causes of toxicity, their translatability into the clinic, as well as mitigation and dosing strategies to limit these toxicities will enable ADC developers to take more assets into the clinic while reducing the costs of failures.

The first-of-its-kind ADC Toxicity Summit will allow companies developing ADCs to overcome toxicological related challenges, by hearing case-study-led presentations on approved ADCs, including ImmunoGen's Mirvetuximab Soravtansine, as well as important scientific and strategic discussions. Designed to provide you with the toolkit to design and deliver more tolerable ADCs to patients without lowering efficacy this is your exclusive opportunity to join peers with expertise in toxicology, safety, and pathology.

Read on

Continue reading at

Related Offerings

Interested in this event?

Next Event

  • July

    AACC 23 - Annual Scientific Meeting & Clinical Lab Expo

     July 25 to July 27, 2023 

    Anaheim, California, United States

    AACC 23 - Annual Scientific Meeting & Clinical Lab Expo

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2024 Netspective Media LLC. All Rights Reserved.

Built on Jun 21, 2024 at 7:13am